[Tree] Indian pharmaceutical industry, Union Budget, tax incentives, research and development, innovative drugs, Mashantucket Pequot Tribal Nation, generic drug manufacturing, drug shortages, STEM workforce development, national security threat, Budget 2024, customs duty, cancer medicines, mobile phones

Version 0.28 (2024-07-23 08:04:01.443000)

updates: Changes in customs duties proposed in Union Budget 2024-25

  • ➔
  • ➔
Version 0.27 (2024-07-12 03:54:04.076000)

updates: Add information about the federal grant received by the Mashantucket Pequot Tribal Nation for pharmaceutical manufacturing

  • ➔
  • ➔
Version 0.26 (2024-07-10 09:56:51.634000)

updates: Generic drug manufacturing by Mashantucket Pequot Tribal Nation in Connecticut

  • ➔
  • ➔
Version 0.25 (2024-07-06 08:55:55.185000)

updates: Indian pharmaceutical industry seeks tax relief and financial support in Union Budget 2024

  • ➔
Version 0.24 (2024-06-25 12:55:05.170000)

updates: Biocon's market share growth in the US for biosimilars

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.23 (2024-06-25 08:55:32.503000)

updates: Jubilant Pharmova repays term loan, improves debt-to-EBITDA ratio

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.22 (2024-06-23 06:53:56.741000)

updates: Lupin and Eugia recall products from US market due to manufacturing issues

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.21 (2024-06-15 11:59:44.748000)

updates: Biocon's Visakhapatnam API facility receives 3 USFDA observations

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.2 (2024-05-28 06:53:46.842000)

updates: Includes Strides Pharma's Q4 results and performance

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.19 (2024-05-28 03:56:59.374000)

updates: Aurobindo Pharma reports strong Q4 results and growth outlook

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.18 (2024-05-27 10:54:47.636000)

updates: Indian drugmakers expected to see revenue boost in the US market due to drug shortages

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.17 (2024-05-23 06:56:36.663000)

updates: Analyst expects 15-18% upside in Sun Pharma stock

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.16 (2024-05-23 04:57:48.656000)

updates: Sun Pharma's Q4 results show steady growth in India and strong growth in the US in Q4

  • ➔
  • ➔
  • ➔
  • ➔
Version 0.15 (2024-05-10 04:54:33.106000)

updates: Inclusion of Alembic Pharma's Q4 results and growth drivers

  • ➔
  • ➔
  • ➔
Version 0.14 (2024-04-20 12:20:49.214000)

updates: Q4 earnings boost from US market, surge in pharmaceutical exports to the United States

  • ➔
  • ➔
Version 0.13 (2024-04-13 06:21:33.291000)

updates: Updated Q4 earnings preview and recommendations

  • ➔
Version 0.12 (2024-04-12 03:30:51.251000)

updates: Updates on India's pharmaceutical industry Q4 earnings

  • ➔
Version 0.11 (2024-04-11 07:19:05.973000)

updates: CII President R Dinesh foresees GDP growth at 8-9% amid global challenges

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.1 (2024-03-31 21:18:44.500000)

updates: Updated information on India's GDP growth and macro-indicators

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.09 (2024-03-30 23:19:10.108000)

updates: Finance Minister Nirmala Sitharaman anticipates GDP growth of 8% or higher for the March quarter. She credits India's energetic population for the economic growth and addresses the surge in income tax notices due to digitization and compliance requirements.

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.08 (2024-03-30 14:22:57.772000)

updates: India's GDP growth projection for Jan-March quarter

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.07 (2024-03-23 15:25:30.902000)

updates: Information about India's gaming industry and the Game Developers Conference in the US

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.06 (2024-03-05 07:20:28.608000)

updates: Inclusion of information about GVA's expansion plans [f2c4edd3]

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.05 (2024-01-09 08:21:40.271000)

updates: Added information about the value retail market in India

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.05 (2024-01-09 08:21:40.271000)

updates: Added information about the value retail market in India

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.04 (2024-01-03 00:10:02.797000)

updates: Integration of information about India's malls forecasted to expand by 116-118 million square feet by 2025

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.03 (2023-12-31 00:08:54.578000)

updates: Updates on Mumbai's real estate market and property registrations

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.02 (2023-12-30 09:05:00.790000)

updates: Inclusion of information about Mumbai's property market surge in sales

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.01 (2023-12-02 06:44:48.078000)

updates: The construction sector's contribution to GDP growth

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.0 (2023-12-02 05:34:40.889000)

updates:

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔